Encompass Health (EHC) Competitors

In the previous week, Encompass Health had 6 more articles in the media than The Ensign Group. MarketBeat recorded 17 mentions for Encompass Health and 11 mentions for The Ensign Group. Encompass Health's average media sentiment score of 1.12 beat The Ensign Group's score of 0.71 indicating that Encompass Health is being referred to more favorably in the media.

Encompass Health pays an annual dividend of $0.76 per share and has a dividend yield of 0.6%. The Ensign Group pays an annual dividend of $0.26 per share and has a dividend yield of 0.1%. Encompass Health pays out 12.4% of its earnings in the form of a dividend. The Ensign Group pays out 4.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Encompass Health has increased its dividend for 2 consecutive years and The Ensign Group has increased its dividend for 18 consecutive years.

97.3% of Encompass Health shares are owned by institutional investors. Comparatively, 96.1% of The Ensign Group shares are owned by institutional investors. 1.8% of Encompass Health shares are owned by insiders. Comparatively, 4.0% of The Ensign Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Encompass Health has a beta of 0.72, indicating that its stock price is 28% less volatile than the broader market. Comparatively, The Ensign Group has a beta of 0.68, indicating that its stock price is 32% less volatile than the broader market.

Encompass Health presently has a consensus price target of $148.71, indicating a potential upside of 21.67%. The Ensign Group has a consensus price target of $216.25, indicating a potential upside of 20.24%. Given Encompass Health's stronger consensus rating and higher probable upside, research analysts clearly believe Encompass Health is more favorable than The Ensign Group.

Encompass Health has higher revenue and earnings than The Ensign Group. Encompass Health is trading at a lower price-to-earnings ratio than The Ensign Group, indicating that it is currently the more affordable of the two stocks.

Encompass Health has a net margin of 10.01% compared to The Ensign Group's net margin of 6.90%. Encompass Health's return on equity of 18.08% beat The Ensign Group's return on equity.

97.3% of Encompass Health shares are owned by institutional investors. Comparatively, 86.1% of Universal Health Services shares are owned by institutional investors. 1.8% of Encompass Health shares are owned by insiders. Comparatively, 17.1% of Universal Health Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Encompass Health presently has a consensus target price of $148.71, suggesting a potential upside of 21.67%. Universal Health Services has a consensus target price of $204.93, suggesting a potential upside of 18.08%. Given Encompass Health's stronger consensus rating and higher possible upside, research analysts clearly believe Encompass Health is more favorable than Universal Health Services.

Universal Health Services has higher revenue and earnings than Encompass Health. Universal Health Services is trading at a lower price-to-earnings ratio than Encompass Health, indicating that it is currently the more affordable of the two stocks.

Encompass Health has a net margin of 10.01% compared to Universal Health Services' net margin of 8.42%. Universal Health Services' return on equity of 19.39% beat Encompass Health's return on equity.

In the previous week, Encompass Health had 12 more articles in the media than Universal Health Services. MarketBeat recorded 17 mentions for Encompass Health and 5 mentions for Universal Health Services. Encompass Health's average media sentiment score of 1.12 beat Universal Health Services' score of 0.80 indicating that Encompass Health is being referred to more favorably in the media.

Encompass Health pays an annual dividend of $0.76 per share and has a dividend yield of 0.6%. Universal Health Services pays an annual dividend of $0.80 per share and has a dividend yield of 0.5%. Encompass Health pays out 12.4% of its earnings in the form of a dividend. Universal Health Services pays out 3.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Encompass Health has increased its dividend for 2 consecutive years. Encompass Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Encompass Health has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market. Comparatively, Universal Health Services has a beta of 1.05, meaning that its share price is 5% more volatile than the broader market.

PACS Group currently has a consensus price target of $56.00, indicating a potential upside of 27.80%. Encompass Health has a consensus price target of $148.71, indicating a potential upside of 21.67%. Given PACS Group's higher probable upside, analysts plainly believe PACS Group is more favorable than Encompass Health.

PACS Group has a beta of -0.08, suggesting that its stock price is 108% less volatile than the broader market. Comparatively, Encompass Health has a beta of 0.72, suggesting that its stock price is 28% less volatile than the broader market.

97.3% of Encompass Health shares are held by institutional investors. 70.1% of PACS Group shares are held by company insiders. Comparatively, 1.8% of Encompass Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Encompass Health has a net margin of 10.01% compared to PACS Group's net margin of 4.85%. PACS Group's return on equity of 29.55% beat Encompass Health's return on equity.

In the previous week, Encompass Health had 6 more articles in the media than PACS Group. MarketBeat recorded 17 mentions for Encompass Health and 11 mentions for PACS Group. Encompass Health's average media sentiment score of 1.12 beat PACS Group's score of 0.35 indicating that Encompass Health is being referred to more favorably in the news media.

Encompass Health has higher revenue and earnings than PACS Group. Encompass Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Encompass Health pays an annual dividend of $0.76 per share and has a dividend yield of 0.6%. Concentra Group Holdings Parent pays an annual dividend of $0.25 per share and has a dividend yield of 0.7%. Encompass Health pays out 12.4% of its earnings in the form of a dividend. Concentra Group Holdings Parent pays out 16.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Encompass Health has increased its dividend for 2 consecutive years.

Encompass Health currently has a consensus price target of $148.71, indicating a potential upside of 21.67%. Concentra Group Holdings Parent has a consensus price target of $37.00, indicating a potential upside of 5.62%. Given Encompass Health's stronger consensus rating and higher possible upside, equities analysts plainly believe Encompass Health is more favorable than Concentra Group Holdings Parent.

97.3% of Encompass Health shares are held by institutional investors. 1.8% of Encompass Health shares are held by insiders. Comparatively, 8.1% of Concentra Group Holdings Parent shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Encompass Health has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market. Comparatively, Concentra Group Holdings Parent has a beta of 0.62, meaning that its share price is 38% less volatile than the broader market.

In the previous week, Encompass Health had 16 more articles in the media than Concentra Group Holdings Parent. MarketBeat recorded 17 mentions for Encompass Health and 1 mentions for Concentra Group Holdings Parent. Encompass Health's average media sentiment score of 1.12 beat Concentra Group Holdings Parent's score of 0.55 indicating that Encompass Health is being referred to more favorably in the media.

Encompass Health has a net margin of 10.01% compared to Concentra Group Holdings Parent's net margin of 8.69%. Concentra Group Holdings Parent's return on equity of 47.81% beat Encompass Health's return on equity.

Encompass Health has higher revenue and earnings than Concentra Group Holdings Parent. Encompass Health is trading at a lower price-to-earnings ratio than Concentra Group Holdings Parent, indicating that it is currently the more affordable of the two stocks.